KR102274449B1 - Fluoranthene compound and organic light emitting element comprising the same - Google Patents

Fluoranthene compound and organic light emitting element comprising the same Download PDF

Info

Publication number
KR102274449B1
KR102274449B1 KR1020190140260A KR20190140260A KR102274449B1 KR 102274449 B1 KR102274449 B1 KR 102274449B1 KR 1020190140260 A KR1020190140260 A KR 1020190140260A KR 20190140260 A KR20190140260 A KR 20190140260A KR 102274449 B1 KR102274449 B1 KR 102274449B1
Authority
KR
South Korea
Prior art keywords
group
substituted
unsubstituted
layer
light emitting
Prior art date
Application number
KR1020190140260A
Other languages
Korean (ko)
Other versions
KR20210054300A (en
Inventor
이상진
정은빈
박도우
국창훈
조은상
Original Assignee
주식회사 진웅산업
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 진웅산업 filed Critical 주식회사 진웅산업
Priority to KR1020190140260A priority Critical patent/KR102274449B1/en
Publication of KR20210054300A publication Critical patent/KR20210054300A/en
Application granted granted Critical
Publication of KR102274449B1 publication Critical patent/KR102274449B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/24Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5022Aromatic phosphines (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H01L51/0067
    • H01L51/0072
    • H01L51/5012
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 플루오란텐 화합물 및 이를 포함하는 유기발광소자에 관한 것이다. 본 발명의 유기발광소자는 본 발명의 플루오란텐 화합물을 포함하여 우수한 구동전압 및 발광효율 특성을 나타낸다.The present invention relates to a fluoranthene compound and an organic light emitting device comprising the same. The organic light emitting diode of the present invention includes the fluoranthene compound of the present invention and exhibits excellent driving voltage and luminous efficiency characteristics.

Description

플루오란텐계 화합물의 유도체 및 이를 포함하는 유기발광소자{FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING THE SAME}Derivatives of fluoranthene-based compounds and organic light emitting devices comprising the same {FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING THE SAME}

본 발명은 전하생성 화합물 및 이를 포함하는 유기 전계발광소자에 관한 것으로, 보다 자세하게는, 유기전계발광 소자의 발광효율을 향상시키고 특히 구동전압을 낮출 수 있는 전하생성 화합물 및 이를 포함하는 신규한 플루오란텐 유도체에 관한 것이다.The present invention relates to a charge generating compound and an organic electroluminescent device including the same, and more particularly, to a charge generating compound capable of improving the luminous efficiency of an organic electroluminescent device and lowering a driving voltage, and a novel fluoran including the same It relates to ten derivatives.

다양한 정보를 화면으로 구현해 주는 영상표시장치는 정보 통신 시대의 핵심 기술로 더 얇고 더 가볍고 휴대가 가능하면서도 고성능의 방향으로 발전하고 있다. 근래 정보화 사회의 발전과 더불어, 표시장치에 대한 다양한 형태의 요구가 증대되면서, LCD(Liquid Crystal Display), PDP(Plasma Display Panel), ELD(Electro Luminescent Display), FED(Field Emission Display), OLED(Organic Light Emitting Diode) 등 평판표시장치에 대한 연구가 활발히 진행되고 있다. 유기발광소자는 유기 물질을 이용하여 전기 에너지를 빛 에너지로 전환하기 위한 소자로서, 애노드(anode)와 캐소드(cathode) 사이에 발광 가능한 유기물층이 형성된 구조를 포함한다. 유기발광소자는 다양한 구조로 형성될 수 있으며, 그 중 복수의 발광층이 적층된 텐덤(Tandem)형 유기발광소자가 연구되고 있다. A video display device that implements various information on a screen is a key technology in the information and communication era, which is developing in the direction of thinner, lighter, more portable and high-performance. With the recent development of the information society, as the demand for various types of display devices increases, LCD (Liquid Crystal Display), PDP (Plasma Display Panel), ELD (Electro Luminescent Display), FED (Field Emission Display), OLED ( Organic Light Emitting Diode) and other flat panel display devices are being actively researched. An organic light emitting device is a device for converting electrical energy into light energy using an organic material, and includes a structure in which a light emitting organic material layer is formed between an anode and a cathode. The organic light emitting device can be formed in various structures, and among them, a tandem type organic light emitting device in which a plurality of light emitting layers are stacked is being studied.

텐덤(Tandem)형 유기발광소자에서는 애노드와 캐소드 사이에 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층을 포함하는 발광부가 복수 개로 적층된다. 텐덤형 유기발광소자에서는 각 발광부들 사이에 전하생성층 및 전자주입층으로 전자가 이동하고 전하생성층과 인접한 정공주입층으로는 정공이 전달된다. 이 때, 전하생성층과의 계면 특성과 에너지 레벨 차이 및 전하생성층과 도핑된 알칼리 금속과의 계면특성과 에너지 레벨 차이에 따라 소자 효율이 결정된다. 전하생성층 사이의 에너지 레벨 차이가 클수록, 전하생성층과 인접한 정공주입층 계면에서 전하가 생성되어 전자가 전하생성층으로 주입되기 어려워진다. 또한, 전하생성층에 알칼리 금속이 도핑된 경우, 알칼리 금속이 전하생성층으로 확산되어 전류 누설이 발생한다. 전류 누설은 소자의 수명을 저하시킨다.In a tandem type organic light emitting device, a plurality of light emitting units including a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer are stacked between an anode and a cathode. In the tandem organic light emitting device, electrons are transferred to the charge generating layer and the electron injection layer between the light emitting units, and holes are transferred to the hole injection layer adjacent to the charge generating layer. At this time, the device efficiency is determined according to the difference in energy level and the interface characteristics between the charge generation layer and the charge generation layer and the interface characteristics and energy level between the charge generation layer and the doped alkali metal. As the energy level difference between the charge generation layers increases, charges are generated at the interface between the charge generation layer and the adjacent hole injection layer, making it difficult for electrons to be injected into the charge generation layer. Also, when the charge generation layer is doped with an alkali metal, the alkali metal diffuses into the charge generation layer and current leakage occurs. Current leakage reduces the lifetime of the device.

특허문헌 1: 한국 등록특허 제10-1645145호Patent Document 1: Korean Patent Registration No. 10-1645145

본 발명은 기존의 재료보다 발광효율이 우수하고 열 안정성이 뛰어난 신규한 플루오란텐 유도체를 제공하는 것이며 또한 상기 플루오란텐 유도체가 유기막에 포함되어 소자의 구동전압을 낮추고 발광 효율이 개선된 유기발광소자를 제공하는 것이다.The present invention is to provide a novel fluoranthene derivative having superior luminous efficiency and excellent thermal stability than conventional materials, and the fluoranthene derivative is included in an organic film to lower the driving voltage of the device and improve luminous efficiency. To provide a light emitting device.

본 발명의 목적은 하기 화학식 1로 표시되는 플루오란텐 화합물에 의해 달성될 수 있다.The object of the present invention can be achieved by a fluoranthene compound represented by the following formula (1).

[화학식 1][Formula 1]

Figure 112019113353101-pat00001
Figure 112019113353101-pat00001

상기 Ar1은 수소, 치환 또는 치환되지 않는 탄소수 3 내지 60의 아릴기, 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 치환 혹은 치환되지 않은 탄소수 3 내지 60의 헤테로아릴기, 아릴아민기 및 2차 아민기로 이루어진 군으로부터 선택된다.Wherein Ar 1 is hydrogen, a substituted or unsubstituted C 3 to C 60 aryl group, a substituted or unsubstituted C 3 to C 60 heteroaryl group including one or more heteroatoms selected from nitrogen, oxygen and sulfur, arylamine group and secondary amine groups.

상기 Ar1은 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트릴기, 치환 또는 비치환된 나프타세닐기, 치환 또는 비치환된 피레닐기, 치환 또는 비치환된 바이페닐일기, 치환 또는 비치환된 p-터페닐기, 치환 또는 비치환된 m-터페닐기, 치환 또는 비치환된 크리세닐기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 페릴레닐기, 치환 또는 비치환된 인데닐기, 치환 또는 비치환된 퓨라닐기, 치환 또는 비치환된 티오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 피라졸릴기, 치환 또는 비치환된 이미다졸일기, 치환 또는 비치환된 트리아졸일기, 치환 또는 비치환된 옥사졸일기, 치환 또는 비치환된 티아졸일기, 치환 또는 비치환된 옥사디아졸일기, 치환 또는 비치환된 티아디아졸일기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 벤조퓨라닐기, 치환 또는 비치환된 벤조티오페닐기, 치환 또는 비치환된 벤조이미다졸일기, 치환 또는 비치환된 인돌일기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 나프티리디닐기, 치환 또는 비치환된 벤즈옥사진일기, 치환 또는 비치환된 벤즈티아진일기, 치환 또는 비치환된 아크리디닐기, 치환 또는 비치환된 페나진일기, 치환 또는 비치환된 페노티아진일기, 치환 또는 비치환된 페녹사진일기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 카바졸릴기, 및 치환 또는 비치환된 스피로비플루오레닐기로 이루어진 군으로부터 선택될 수 있다.Wherein Ar 1 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthryl group, a substituted or unsubstituted naphthacenyl group, a substituted or unsubstituted a pyrenyl group, a substituted or unsubstituted biphenylyl group, a substituted or unsubstituted p-terphenyl group, a substituted or unsubstituted m-terphenyl group, a substituted or unsubstituted chrysenyl group, a substituted or unsubstituted triphenyl group Nyl group, substituted or unsubstituted perylenyl group, substituted or unsubstituted indenyl group, substituted or unsubstituted furanyl group, substituted or unsubstituted thiophenyl group, substituted or unsubstituted pyrrolyl group, substituted or unsubstituted pyrazolyl group group, a substituted or unsubstituted imidazolyl group, a substituted or unsubstituted triazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted oxadiazolyl group, a substituted or Unsubstituted thiadiazolyl group, substituted or unsubstituted pyridyl group, substituted or unsubstituted pyrimidinyl group, substituted or unsubstituted pyrazinyl group, substituted or unsubstituted triazinyl group, substituted or unsubstituted benzofura nyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted benzoimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, a substituted or Unsubstituted quinazolinyl group, substituted or unsubstituted quinoxalinyl group, substituted or unsubstituted naphthyridinyl group, substituted or unsubstituted benzoxazinyl group, substituted or unsubstituted benzthiazinyl group, substituted or unsubstituted an acridinyl group, a substituted or unsubstituted phenazinyl group, a substituted or unsubstituted phenothiazinyl group, a substituted or unsubstituted phenoxazinyl group, a substituted or unsubstituted phenanthrolinyl group, a substituted or unsubstituted carbazolyl group, And it may be selected from the group consisting of a substituted or unsubstituted spirobifluorenyl group.

또한, 본 발명의 목적은 제1전극, 제2전극, 및 상기 제1전극과 제2전극 사이에 위치하는 1층 이상의 유기물층을 포함하며, 상기 유기물층 중 1층 이상은 본 발명에 따른 플루오란텐 화합물을 포함하는 유기발광소자에 의해 달성된다.In addition, an object of the present invention includes a first electrode, a second electrode, and at least one organic material layer positioned between the first electrode and the second electrode, wherein at least one of the organic material layers is fluoranthene according to the present invention It is achieved by an organic light emitting device comprising a compound.

상기 유기물층은 발광층, 정공주입층, 정공수송층, 및 정공주입 및 정공수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하고, 상기 적어도 1개의 층은 본 발명에 따른 플루오란텐 화합물을 포함할 수 있다.The organic layer includes at least one layer selected from the group consisting of a light emitting layer, a hole injection layer, a hole transport layer, and a layer that simultaneously injects and transports holes, and the at least one layer is a fluoranthene compound according to the present invention may include.

상기 유기물층은 발광층, 전자주입층, 전자수송층, 및 전자주입 및 전자수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하고, 상기 적어도 1개의 층은 본 발명에 따른 플루오란텐 화합물을 포함할 수 있다.The organic layer includes at least one layer selected from the group consisting of a light emitting layer, an electron injection layer, an electron transport layer, and a layer that simultaneously injects and transports electrons, and the at least one layer is a fluoranthene compound according to the present invention may include.

상기 유기물층은 적어도 1개의 전하생성층(Charge Generation Layer: CGL)을 포함하고, 상기 적어도 1개의 전하생성층은 본 발명에 따른 플루오란텐 화합물을 포함할 수 있다.The organic material layer may include at least one charge generation layer (CGL), and the at least one charge generation layer may include the fluoranthene compound according to the present invention.

본 발명의 일 실시예에 따른 플루오란텐 화합물은 유기 전계 발광소자의 유기막, 바람직하게는 전하생성층, 정공주입층 또는 정공수송층에 포함되어 소자의 구동전압을 낮추고 발광효율을 개선할 수 있다. 또한, 본 발명의 플루오란텐 화합물의 열적 안정성에 의해 유기전계발광소자의 수명을 개선할 수 있다.The fluoranthene compound according to an embodiment of the present invention may be included in an organic film, preferably, a charge generating layer, a hole injection layer or a hole transport layer of an organic electroluminescent device to lower the driving voltage of the device and improve luminous efficiency. . In addition, the lifespan of the organic electroluminescent device can be improved by the thermal stability of the fluoranthene compound of the present invention.

도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다.1 is a cross-sectional view of an organic light emitting device according to an embodiment of the present invention.

본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 것이며, 단지 본 실시예들은 본 발명의 개시가 완전하도록 하며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다. Advantages and features of the present invention, and methods of achieving them, will become apparent with reference to the embodiments described below in detail. However, the present invention is not limited to the embodiments disclosed below, but will be implemented in a variety of different forms, and only these embodiments allow the disclosure of the present invention to be complete, and common knowledge in the technical field to which the present invention belongs It is provided to fully inform the possessor of the scope of the invention, and the present invention is only defined by the scope of the claims.

도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 도시된 것이며, 본 발명이 도시된 구성의 크기 및 두께에 반드시 한정되는 것은 아니다.The size and thickness of each component shown in the drawings are illustrated for convenience of description, and the present invention is not necessarily limited to the size and thickness of the illustrated component.

이하, 첨부된 도면을 참조하여 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

본 발명에 다른 플루오란텐 화합물은 하기 화학식 1로 표시된다.The fluoranthene compound according to the present invention is represented by the following formula (1).

[화학식 1][Formula 1]

Figure 112019113353101-pat00002
Figure 112019113353101-pat00002

상기 Ar1은 수소, 치환 또는 치환되지 않는 탄소수 3 내지 60의 아릴기, 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 치환 혹은 치환되지 않은 탄소수 3 내지 60의 헤테로아릴기, 아릴아민기 및 2차 아민기로 이루어진 군으로부터 선택된다.Wherein Ar 1 is hydrogen, a substituted or unsubstituted C 3 to C 60 aryl group, a substituted or unsubstituted C 3 to C 60 heteroaryl group including one or more heteroatoms selected from nitrogen, oxygen and sulfur, arylamine group and secondary amine groups.

상기 Ar1은 구체적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트릴기, 치환 또는 비치환된 나프타세닐기, 치환 또는 비치환된 피레닐기, 치환 또는 비치환된 바이페닐일기, 치환 또는 비치환된 p-터페닐기, 치환 또는 비치환된 m-터페닐기, 치환 또는 비치환된 크리세닐기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 페릴레닐기, 치환 또는 비치환된 인데닐기, 치환 또는 비치환된 퓨라닐기, 치환 또는 비치환된 티오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 피라졸릴기, 치환 또는 비치환된 이미다졸일기, 치환 또는 비치환된 트리아졸일기, 치환 또는 비치환된 옥사졸일기, 치환 또는 비치환된 티아졸일기, 치환 또는 비치환된 옥사디아졸일기, 치환 또는 비치환된 티아디아졸일기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 벤조퓨라닐기, 치환 또는 비치환된 벤조티오페닐기, 치환 또는 비치환된 벤조이미다졸일기, 치환 또는 비치환된 인돌일기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 나프티리디닐기, 치환 또는 비치환된 벤즈옥사진일기, 치환 또는 비치환된 벤즈티아진일기, 치환 또는 비치환된 아크리디닐기, 치환 또는 비치환된 페나진일기, 치환 또는 비치환된 페노티아진일기, 치환 또는 비치환된 페녹사진일기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 스피로비플루오레닐기 또는 이들의 조합일 수 있으나, 이에 제한되지는 않는다. 바람직하게는, 상기 Ar1은 치환 또는 비치환된 페닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 벤조이미다졸릴기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 스피로비플루오레닐기, 치환 또는 비치환된 포스핀옥사이드기, 및 이들의 조합으로 이루어진 군으로부터 선택될 수 있다.Wherein Ar 1 is specifically a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthryl group, a substituted or unsubstituted naphthacenyl group, a substituted or Unsubstituted pyrenyl group, substituted or unsubstituted biphenylyl group, substituted or unsubstituted p-terphenyl group, substituted or unsubstituted m-terphenyl group, substituted or unsubstituted chrysenyl group, substituted or unsubstituted tree A phenylenyl group, a substituted or unsubstituted perylenyl group, a substituted or unsubstituted indenyl group, a substituted or unsubstituted furanyl group, a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted A pyrazolyl group, a substituted or unsubstituted imidazolyl group, a substituted or unsubstituted triazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted oxadiazolyl group, A substituted or unsubstituted thiadiazolyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted A benzofuranyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted benzoimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, A substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted naphthyridinyl group, a substituted or unsubstituted benzoxazinyl group, a substituted or unsubstituted benzthiazinyl group, a substituted or unsubstituted A substituted acridinyl group, a substituted or unsubstituted phenazinyl group, a substituted or unsubstituted phenothiazinyl group, a substituted or unsubstituted phenoxazinyl group, a substituted or unsubstituted phenanthrolinyl group, a substituted or unsubstituted carbazolyl group group, a substituted or unsubstituted spirobifluorenyl group, or a combination thereof, but is not limited thereto. Preferably, Ar 1 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted phenanthrolinyl group, a substituted or unsubstituted benzoimidazolyl group, a substituted or unsubstituted tree A phenylenyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted spirobifluorenyl group, a substituted or unsubstituted phosphine oxide group , and combinations thereof.

상기 Ar1에 치환될 수 있는 치환기는 페닐기, 나프틸기, 안트라세닐기, 페난트릴기, 나프타세닐기, 피레닐기, 바이페닐일기, p-터페닐기, m-터페닐기, 크리세닐기, 트리페닐레닐기, 페릴레닐기, 인데닐기, 퓨라닐기, 티오페닐기, 피롤릴기, 피라졸릴기, 이미다졸일기, 트리아졸일기, 옥사졸일기, 티아졸일기, 옥사디아졸일기, 티아디아졸일기, 피리딜기, 피리미디닐기, 피라지닐기, 트리아지닐기, 벤조퓨라닐기, 벤조티오페닐기, 벤조이미다졸일기, 인돌일기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴나졸리닐기, 퀴녹살리닐기, 나프티리디닐기, 벤즈옥사진일기, 벤즈티아진일기, 아크리디닐기, 페나진일기, 페노티아진일기, 페녹사진일기, 포스핀옥사이드기, 페난트롤리닐기, 카바졸릴기 및 스피로비플루오레닐기로 구성된 군으로부터 선택될 수 있다.Substituents that may be substituted for Ar 1 are phenyl group, naphthyl group, anthracenyl group, phenanthryl group, naphthacenyl group, pyrenyl group, biphenylyl group, p-terphenyl group, m-terphenyl group, chrysenyl group, triphenyl Renyl group, perylenyl group, indenyl group, furanyl group, thiophenyl group, pyrrolyl group, pyrazolyl group, imidazolyl group, triazolyl group, oxazolyl group, thiazolyl group, oxadiazolyl group, thiadiazolyl group, pyri Diyl group, pyrimidinyl group, pyrazinyl group, triazinyl group, benzofuranyl group, benzothiophenyl group, benzoimidazolyl group, indolyl group, quinolinyl group, isoquinolinyl group, quinazolinyl group, quinoxalinyl group, naphthyridinyl group , from the group consisting of benzoxazinyl group, benzthiazinyl group, acridinyl group, phenazinyl group, phenothiazinyl group, phenoxazinyl group, phosphine oxide group, phenanthrolinyl group, carbazolyl group and spirobifluorenyl group can be chosen.

구체적인 예를 들어, 본 발명에 따른 플루오란텐 화합물은 하기 표시되는 화합물일 수 있다.As a specific example, the fluoranthene compound according to the present invention may be a compound shown below.

Figure 112019113353101-pat00003
Figure 112019113353101-pat00003

본 발명의 플루오란텐 화합물은 기존의 사용되는 디메틸플루오렌(dimethylfluorene)보다 높은 전류효율과 전자이동도 상승을 위해서 컨쥬게이션이 증가된 화합물로 설계하였다. 그 결과 화합물의 화합물의 안정성이 좋아지고 밴드갭이 줄어드는 효과가 있다. 또한 전자의 이동이 쉽게 되어 소자 제작 시 전류효율 상승한다. 특히, 전자 수송능력을 가지는 N을 포함하는 다중고리 화합물이나 P가 포함된 화합물이 치환되는 경우 전하생성능력과 전자수송능력의 안정성이 확보된다. The fluoranthene compound of the present invention was designed as a compound with increased conjugation for higher current efficiency and higher electron mobility than the conventionally used dimethylfluorene. As a result, the stability of the compound of the compound is improved and the band gap is reduced. In addition, the electrons move easily and the current efficiency increases during device fabrication. In particular, when a polycyclic compound containing N having an electron transport ability or a compound containing P is substituted, the stability of the charge generating ability and the electron transporting ability is secured.

도 1은 본 발명의 일 실시예에 따른 유기발광소자의 단면도이다. 도 1을 참조하면, 유기발광소자(1)는 탄뎀형 구조로서 제1전극(양극, 110), 제2전극(음극, 120), 제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)을 포함한다.1 is a cross-sectional view of an organic light emitting device according to an embodiment of the present invention. Referring to FIG. 1 , the organic light-emitting device 1 has a tandem-type structure, including a first electrode (anode, 110), a second electrode (cathode, 120), a first light-emitting unit 210, and a second light-emitting unit 220. , a third light emitting unit 230 , a first charge generating layer 240 , and a second charge generating layer 250 .

제1발광부(210), 제2발광부(220), 제3발광부(230), 제1전하생성층(240) 및 제2전하생성층(250)은 유기물층으로서 제1전극(110)과 제2전극(120) 사이에 위치하며, 제1전하생성층(240)은 제1발광부(210)와 제2발광부(220) 사이에 위치하고, 제2전하생성층(250)은 제2발광부(220)와 제3발광부(230) 사이에 위치한다.The first light emitting unit 210 , the second light emitting unit 220 , the third light emitting unit 230 , the first charge generating layer 240 , and the second charge generating layer 250 are organic material layers and the first electrode 110 . It is positioned between the second electrode 120 and the first charge generating layer 240 is positioned between the first light emitting part 210 and the second light emitting part 220, and the second charge generating layer 250 is the second It is positioned between the second light emitting unit 220 and the third light emitting unit 230 .

제1발광부(210)는 정공주입층(211), 제1정공수송층(212), 제1발광층(213), 제1전자수송층(214)으로 이루어져 있으며, 제2발광부(220)는 제2정공수송층(221), 제2발광층(222) 및 제2전자수송층(223)으로 이루어져 있고, 제3발광부(230)는 제3정공수송층(231), 제3발광층(232), 제3전자수송층(233) 및 전자주입층(234)으로 이루어져 있다.The first light emitting unit 210 includes a hole injection layer 211 , a first hole transport layer 212 , a first light emitting layer 213 , and a first electron transport layer 214 , and the second light emitting unit 220 is a second light emitting unit 220 . The second hole transport layer 221 , the second light emitting layer 222 and the second electron transport layer 223 are formed, and the third light emitting unit 230 includes a third hole transport layer 231 , a third light emitting layer 232 , and a third It consists of an electron transport layer 233 and an electron injection layer 234 .

제1전하생성층(240)은 n형 전하생성층(241)과 p형 전하생성층(242)으로 이루어져 있으며, 제2전하생성층(250)은 n형 전하생성층(251)과 p형 전하생성층(252)으로 이루어져 있다. n형 전하생성층(241, 251)은 알칼리 금속으로 도핑되어 있을 수 있다.The first charge generation layer 240 includes an n-type charge generation layer 241 and a p-type charge generation layer 242 , and the second charge generation layer 250 includes an n-type charge generation layer 251 and a p-type charge generation layer 251 . and a charge generation layer 252 . The n-type charge generation layers 241 and 251 may be doped with an alkali metal.

본 발명에 따른 플루오란텐 화합물은 제1전자수송층(214), 제2전자수송층(223), 제3전자수송층(233), 전자주입층(234), 제1전하생성층(240) 및/또는 제2전하생성층(250)에 포함되어 사용될 수 있으며, 특히 n형 전하생성층(241, 251)에 사용될 수 있다.The fluoranthene compound according to the present invention includes a first electron transport layer 214, a second electron transport layer 223, a third electron transport layer 233, an electron injection layer 234, a first charge generation layer 240 and / Alternatively, it may be included in the second charge generation layer 250 , and in particular, may be used in the n-type charge generation layers 241 and 251 .

설명한 유기발광소자(1)는 다양하게 변형가능하다. 일부 유기층은 생략되거나 추가될 수 있으며, 텐덤형태가 아닐 수 있으며, 2개 또는 4개 이상의 발광층을 가지는 텐덤형태일 수도 있다. 또한, 유기발광소자(1)는 전자수송과 전자주입을 동시에 하는 층을 포함하는 유기층을 포함할 수 있으며, 이러한 경우에도 본 발명에 따른 플루오란텐 화합물이 사용될 수 있다.The described organic light emitting device 1 can be variously modified. Some organic layers may be omitted or added, may not be in a tandem form, and may be in a tandem form having two or four or more light emitting layers. In addition, the organic light emitting device 1 may include an organic layer including a layer that simultaneously transports and injects electrons, and even in this case, the fluoranthene compound according to the present invention may be used.

이하에서는 본 발명에 따른 플루오란텐 화합물의 제조예 및 유기발광소자의 실시예 및 비교예를 설명한다. 다만, 하기에 기재된 제조예 및 실시예는 본 발명을 구체적으로 예시하거나 설명하기 위한 것일 뿐이며, 이하에 기재된 제조예 및 실시예에 의해 본 발명을 제한하여 해석해서는 안 된다.Hereinafter, Examples and Comparative Examples of the preparation of the fluoranthene compound and the organic light emitting device according to the present invention will be described. However, the Preparation Examples and Examples described below are only for specifically illustrating or explaining the present invention, and should not be construed as limiting the present invention by the Preparation Examples and Examples described below.

실시예Example

화합물 1-1의 합성Synthesis of compound 1-1

중간체 A (2-(9,9-dimethyl-9H-fluoren-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 합성 Intermediate A (2-(9,9-dimethyl-9H-fluoren-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) synthesis

Figure 112019113353101-pat00004
Figure 112019113353101-pat00004

둥근 바닥 플라스크에 4-bromo-9,9-dimethyl-9H-fluorene(20g, 73mmol)을 가한 후 bis(pinacolato)diboron (14g, 95mmol), potassium acetate(21g, 220mmol), PdCl2(dppf)(1.6g, 2.2mmol)을 가하였다. 1,4-dioxane 200 mL를 가하여 12 시간 동안 환류시켰다. 반응이 종결되면 과량의 메탄올로 석출한 후 필터, 건조하였다. 헥산으로 컬럼정제하고 메탄올로 재결정하여 중간체 A를 11g(48%) 얻었다. EI, MS m/z (%): 320 (100, M+)After adding 4-bromo-9,9-dimethyl-9H-fluorene (20g, 73mmol) to a round bottom flask, bis(pinacolato)diboron (14g, 95mmol), potassium acetate (21g, 220mmol), PdCl 2 (dppf) ( 1.6 g, 2.2 mmol) was added. 200 mL of 1,4-dioxane was added and refluxed for 12 hours. When the reaction was completed, it was precipitated with an excess of methanol, filtered and dried. After column purification with hexane and recrystallization with methanol, 11 g (48%) of Intermediate A was obtained. EI, MS m/z (%): 320 (100, M + )

중간체 B (4-(8-bromonaphthalen-1-yl)-9,9-dimethyl-9H-fluorene) 합성Intermediate B (4-(8-bromonaphthalen-1-yl)-9,9-dimethyl-9H-fluorene) synthesis

Figure 112019113353101-pat00005
Figure 112019113353101-pat00005

둥근 바닥 플라스크에 중간체 A(11g, 34mmol), 1,8-dibromonaphthalene(20g, 69mmol), Pd(pph3)4 (1.2g, 1.03mmol)을 가한 후 톨루엔 110ml, 에탄올 55ml와 잘 섞었다. 증류수 55ml에 potassium carbonate (14g, 103mmol)을 녹인 후 플라스크에 가하였다. 12 시간 동안 환류시킨 후 실온으로 식혀준 뒤 methylene chloride로 추출하였다. 유기층을 분리하여 MgSO4로 건조하였다. 반응물을 헥산으로 컬럼 정제하여 중간체 B를 11.7g(83%) 얻었다. EI, MS m/z (%): 398 (100, M+)Intermediate A (11 g, 34 mmol), 1,8-dibromonaphthalene (20 g, 69 mmol), and Pd (pph 3 ) 4 (1.2 g, 1.03 mmol) were added to a round-bottom flask, and then mixed well with 110 ml of toluene and 55 ml of ethanol. After dissolving potassium carbonate (14g, 103mmol) in 55ml of distilled water, it was added to the flask. After refluxing for 12 hours, the mixture was cooled to room temperature and extracted with methylene chloride. The organic layer was separated and dried over MgSO 4 . The reaction product was purified by column with hexane to obtain 11.7 g (83%) of Intermediate B. EI, MS m/z (%): 398 (100, M + )

중간체 C (6,6-dimethyl-6H-indeno[1,2-j]fluoranthene) 합성 Synthesis of Intermediate C (6,6-dimethyl-6H-indeno[1,2-j]fluoranthene)

Figure 112019113353101-pat00006
Figure 112019113353101-pat00006

둥근 바닥 플라스크에 중간체 B(11g, 27mmol), Pd(pph3)2Br2 (1g, 1.38mmol), 1,8-Diazabicyclo(5.4.0)undec-7-ene(42g, 275mmol)을 Dimethyformamide(110ml)에 잘 녹인 후 24 시간 동안 환류하였다. 반응이 종결되면 증류수를 가하여 석출시킨 후 필터링하여 건조하였다. 헥산으로 컬럼 정제하여 중간체 C를 6.7g(77%)을 얻었다. EI, MS m/z (%): 318 (100, M+)Dimethyformamide (Intermediate B (11 g, 27 mmol), Pd(pph 3 ) 2 Br 2 (1 g, 1.38 mmol), 1,8-Diazabicyclo (5.4.0) undec-7-ene (42 g, 275 mmol) in a round bottom flask 110ml) and refluxed for 24 hours. Upon completion of the reaction, distilled water was added to precipitate, followed by filtering and drying. Column purification with hexane gave 6.7 g (77%) of Intermediate C. EI, MS m/z (%): 318 (100, M + )

중간체 D (8-bromo-6,6-dimethyl-6H-indeno[1,2-j]fluoranthene) 합성Intermediate D (8-bromo-6,6-dimethyl-6H-indeno[1,2-j]fluoranthene) synthesis

Figure 112019113353101-pat00007
Figure 112019113353101-pat00007

둥근 바닥 플라스크에 중간체 C (6.5g, 20mmol), N-bromosuccinimide(4g, 22mmol), acetic acid (0.3ml)를 가한 후 chloroform(65ml)에 잘 녹인다. 12 시간 동안 교반한 후 실온으로 식혀주었다. Methylene chloride로 추출한 후 유기층을 분리하고 MgSO4로 건조하였다. 정제 없이 다음 반응에 사용하였다. EI, MS m/z (%): 396 (100, M+)Intermediate C (6.5g, 20mmol), N-bromosuccinimide (4g, 22mmol), and acetic acid (0.3ml) were added to a round bottom flask, and dissolved in chloroform (65ml). After stirring for 12 hours, it was cooled to room temperature. After extraction with methylene chloride, the organic layer was separated and dried over MgSO 4 . It was used in the next reaction without purification. EI, MS m/z (%): 396 (100, M + )

중간체 E 1-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)ethanoneIntermediate E 1-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)ethanone

Figure 112019113353101-pat00008
Figure 112019113353101-pat00008

둥근 바닥 플라스크에 중간체 D 혼합물(5g, 12.5mmol)을 가한 후 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone (3.7g, 15mmol), Pd(pph3)4 (0.4g, 0.35mmol)을 가한 후 톨루엔 50ml, 에탄올 25ml와 잘 섞어 주었다. 증류수 25ml에 potassium carbonate (5g, 38mmol)을 녹인 후 플라스크에 가하였다. 24 시간 동안 환류시킨 후 실온으로 식혀 준 뒤 과량의 메탄올로 석출시켜 여과 후 건조하였다. 헥산으로 컬럼 정제하여 중간체 E를 3g(54%) 얻었다. EI, MS m/z (%): 436 (100, M+)After adding Intermediate D mixture (5g, 12.5mmol) to a round bottom flask, 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone (3.7g , 15mmol), Pd(pph 3 ) 4 (0.4g, 0.35mmol) was added, and then mixed well with 50ml of toluene and 25ml of ethanol. After dissolving potassium carbonate (5g, 38mmol) in 25ml of distilled water, it was added to the flask. After refluxing for 24 hours, the mixture was cooled to room temperature, precipitated with excess methanol, filtered and dried. Column purification with hexane gave 3 g (54%) of Intermediate E. EI, MS m/z (%): 436 (100, M + )

화합물 1-1 2-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-1,10-phenanthroline의 합성Compound 1-1 Synthesis of 2-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-1,10-phenanthroline

Figure 112019113353101-pat00009
Figure 112019113353101-pat00009

둥근 바닥 플라스크에 중간체 E(3g, 6.87mmol)와 8-aminoquinoline-7-carbaldehyde(1.4g, 8.24mmol), 톨루엔(30ml)을 가하였다. 에탄올(15ml)에 potassium hydroxide(1.16g, 20mmol)을 녹여 반응물에 가한 후 4 시간 동안 환류시켰다. 반응이 종결되면 과량의 물과 메탄올로 석출시켜 여과 후 건조하였다. Methylene chloride로 컬럼 정제하여 화합물 1-1을 2.4g(61%)을 얻었다. EI, MS m/z (%): 572 (100, M+)Intermediate E (3g, 6.87mmol), 8-aminoquinoline-7-carbaldehyde (1.4g, 8.24mmol), and toluene (30ml) were added to a round bottom flask. After dissolving potassium hydroxide (1.16g, 20mmol) in ethanol (15ml), it was added to the reaction product and refluxed for 4 hours. When the reaction was completed, it was precipitated with excess water and methanol, filtered and dried. Column purification was performed with methylene chloride to obtain 2.4 g (61%) of compound 1-1. EI, MS m/z (%): 572 (100, M + )

화합물 1-3의 합성Synthesis of compound 1-3

중간체 F 2,4-diphenyl-6-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine의 합성Intermediate F Synthesis of 2,4-diphenyl-6-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine

Figure 112019113353101-pat00010
Figure 112019113353101-pat00010

둥근 바닥 플라스크에 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (10g, 25mmol)을 가한 후 bis(pinacolato)diboron (8.3g, 33mmol), potassium acetate(7.5g, 77mmol), Pd(dppf)Cl2(5.1g, 0.77mmol)을 가하였다. 1,4-dioxane 100mL를 가하여 12 시간 동안 환류시켰다. 반응이 종결되면 과량의 메탄올로 석출한 후 필터링 및 건조하였다. 헥산으로 컬럼 정제하고 메탄올로 재결정하여 중간체 F를 9.8g(90%) 얻었다. EI, MS m/z (%): 435 (100, M+)After adding 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (10g, 25mmol) to a round bottom flask, bis(pinacolato)diboron (8.3g, 33mmol), potassium acetate (7.5g) , 77mmol), Pd(dppf)Cl 2 (5.1g, 0.77mmol) was added. 100 mL of 1,4-dioxane was added and refluxed for 12 hours. When the reaction was completed, it was precipitated with an excess of methanol, filtered and dried. Column purification with hexane and recrystallization with methanol gave 9.8 g (90%) of Intermediate F. EI, MS m/z (%): 435 (100, M + )

화합물 1-3 2-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-4,6-diphenyl-1,3,5-triazine의 제조Preparation of compound 1-3 2-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-4,6-diphenyl-1,3,5-triazine

Figure 112019113353101-pat00011
Figure 112019113353101-pat00011

둥근 바닥 플라스크에 중간체 D 혼합물(5g, 12.5mmol)을 가한 후 중간체 F (6.5g, 15mmol), Pd(Pph3)4 (0.4g, 0.35mmol)을 가한 후 톨루엔 50ml, 에탄올 25ml와 잘 섞어주었다. 증류수 25ml에 potassium carbonate (5g, 38mmol)을 녹인 후 플라스크에 가하였다. 24시간 동안 환류시킨 후 실온으로 식혀준 뒤 과량의 메탄올로 석출시켜 여과 후 건조하였다. 헥산으로 컬럼 정제하여 화합물 1-3을 5.4g(70%) 얻었다. EI, MS m/z (%): 625 (100, M+)After adding Intermediate D mixture (5g, 12.5mmol) to a round bottom flask, Intermediate F (6.5g, 15mmol), Pd(Pph 3 ) 4 (0.4g, 0.35mmol) was added, and then mixed well with toluene 50ml and ethanol 25ml . After dissolving potassium carbonate (5g, 38mmol) in 25ml of distilled water, it was added to the flask. After refluxing for 24 hours, the mixture was cooled to room temperature, precipitated with excess methanol, filtered and dried. Column purification with hexane gave 5.4 g (70%) of compound 1-3. EI, MS m/z (%): 625 (100, M + )

화합물 1-5의 합성Synthesis of compounds 1-5

중간체 G 2-(4-bromophenyl)-2,7a-dihydro-1H-benzo[d]imidazole의 합성Synthesis of intermediate G 2-(4-bromophenyl)-2,7a-dihydro-1H-benzo[d]imidazole

Figure 112019113353101-pat00012
Figure 112019113353101-pat00012

둥근 바닥 플라스크에 o-Phenylenediamine(10g, 92mmol)을 가한 후 ammonium acetate(27g, 276mmol)을 에탄올에 잘 녹여주었다. 4-bromobenzaldehyde (18.4g, 101mmol)를 에탄올에 녹인 후 반응액에 천천히 가하고 환류시켰다. 반응이 종결되면 농축 후 헥산으로 컬럼 정제하여 중간체 G를 15g(58%) 얻었다. EI, MS m/z (%): 274 (100, M+)After adding o-Phenylenediamine (10 g, 92 mmol) to a round-bottom flask, ammonium acetate (27 g, 276 mmol) was dissolved in ethanol. After dissolving 4-bromobenzaldehyde (18.4 g, 101 mmol) in ethanol, it was slowly added to the reaction solution and refluxed. When the reaction was completed, 15 g (58%) of intermediate G was obtained by concentration and column purification with hexane. EI, MS m/z (%): 274 (100, M + )

중간체 H 2-(4-bromophenyl)-1-ethyl-2,7a-dihydro-1H-benzo[d]imidazole의 합성Synthesis of intermediate H 2-(4-bromophenyl)-1-ethyl-2,7a-dihydro-1H-benzo[d]imidazole

Figure 112019113353101-pat00013
Figure 112019113353101-pat00013

둥근 바닥 플라스크에 중간체 G(11g, 40mmol)를 가한 후 sodium hydride(2.8g, 120mmol)를 가하고 THF에 잘 녹여주었다. Iodoethane (6.2g, 40mmol)을 THF에 잘 녹인 후 반응액에 천천히 가한 후 환류시켰다. 반응이 종결되면 농축 후 헥산으로 컬럼 정제하여 중간체 H를 11g(91%) 얻었다. EI, MS m/z (%): 302 (100, M+)Intermediate G (11g, 40mmol) was added to a round bottom flask, and sodium hydride (2.8g, 120mmol) was added thereto and dissolved in THF. Iodoethane (6.2g, 40mmol) was well dissolved in THF and then slowly added to the reaction solution and refluxed. When the reaction was completed, 11 g (91%) of intermediate H was obtained by concentration and column purification with hexane. EI, MS m/z (%): 302 (100, M + )

중간체 I 1-ethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,7a-dihydro-1H-benzo[d]imidazole의 합성Intermediate I 1-ethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,7a-dihydro-1H-benzo[d]imidazole synthesis of

Figure 112019113353101-pat00014
Figure 112019113353101-pat00014

둥근 바닥 플라스크에 중간체 H (10g, 33mmol)을 가한 후 bis(pinacolato)diboron (9g, 36mmol), potassium acetate(9.7g, 99mmol), Pd(dppf)Cl2(0.09g, 0.99mmol)을 가하였다. 1,4-dioxane 100 mL를 가하여 12시간 동안 환류시켰다. 반응이 종결되면 과량의 메탄올로 석출한 후 여과 및 건조하였다. 헥산으로 컬럼 정제하고 메탄올로 재결정하여 중간체 I를 8g(69%) 얻었다. EI, MS m/z (%): 350 (100, M+)Intermediate H (10g, 33mmol) was added to a round bottom flask, and bis(pinacolato)diboron (9g, 36mmol), potassium acetate (9.7g, 99mmol), Pd(dppf)Cl 2 (0.09g, 0.99mmol) was added thereto. . 100 mL of 1,4-dioxane was added and refluxed for 12 hours. When the reaction was completed, it was precipitated with an excess of methanol, filtered and dried. 8g (69%) of Intermediate I was obtained by column purification with hexane and recrystallization with methanol. EI, MS m/z (%): 350 (100, M+)

화합물 1-5 2-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-1-ethyl-2,7a-dihydro-1H-benzo[d]imidazole의 제조Compound 1-5 2-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-1-ethyl-2,7a-dihydro-1H-benzo[d ]Preparation of imidazole

Figure 112019113353101-pat00015
Figure 112019113353101-pat00015

둥근 바닥 플라스크에 중간체 D 혼합물 (5g, 12.5mmol)을 가한 후 중간체 I (5.2g, 15mmol), Pd(Pph3)4 (0.4g, 0.35mmol)을 가한 후 톨루엔 50ml, 에탄올 25ml와 잘 섞어주었다. 증류수 25ml에 potassium carbonate (5g, 38mmol)을 녹인 후 플라스크에 가하였다. 24 시간 동안 환류시킨 후 실온으로 식혀준 뒤 과량의 메탄올로 석출시켜 여과 후 건조하였다. 헥산으로 컬럼 정제하여 화합물 1-5를 4.2g(63%) 얻었다. EI, MS m/z (%): 540 (100, M+)After adding Intermediate D mixture (5g, 12.5mmol) to a round bottom flask, Intermediate I (5.2g, 15mmol), Pd(Pph 3 ) 4 (0.4g, 0.35mmol) was added, and then mixed well with toluene 50ml and ethanol 25ml . After dissolving potassium carbonate (5g, 38mmol) in 25ml of distilled water, it was added to the flask. After refluxing for 24 hours, the mixture was cooled to room temperature, precipitated with excess methanol, filtered and dried. Column purification was performed with hexane to obtain 4.2 g (63%) of compound 1-5. EI, MS m/z (%): 540 (100, M+)

화합물 1-9 (4'-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-3,2':6',3''-terpyridine)의 합성Compound 1-9 (4'-(4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-8-yl)phenyl)-3,2':6',3''-terpyridine ) synthesis

Figure 112019113353101-pat00016
Figure 112019113353101-pat00016

둥근 바닥 플라스크에 중간체 D 혼합물 (5g, 12.5mmol)을 가한 후 4'-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3,2':6',3''-terpyridine(6.5g, 15mmol), Pd(Pph3)4 (0.4g, 0.35mmol)을 가한 후 톨루엔 50ml, 에탄올 25ml와 잘 섞어주었다. 증류수 25ml에 potassium carbonate (5g, 38mmol)을 녹인 후 플라스크에 가하였다. 24 시간 동안 환류시킨 후 실온으로 식혀준 뒤 과량의 메탄올로 석출시켜 여과 후 건조하였다. Methylene chloride로 컬럼 정제하여 화합물 1-9를 5.4g(70%) 얻었다. EI, MS m/z (%): 626 (100, M+)After adding the intermediate D mixture (5 g, 12.5 mmol) to a round bottom flask, 4'-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3, 2':6',3''-terpyridine (6.5g, 15mmol), Pd(Pph 3 ) 4 (0.4g, 0.35mmol) was added, and then mixed well with 50ml of toluene and 25ml of ethanol. After dissolving potassium carbonate (5g, 38mmol) in 25ml of distilled water, it was added to the flask. After refluxing for 24 hours, the mixture was cooled to room temperature, precipitated with excess methanol, filtered and dried. Column purification with methylene chloride gave 5.4 g (70%) of compound 1-9. EI, MS m/z (%): 626 (100, M+)

화합물 1-10 ((4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-4-yl)phenyl)diphenylphosphine oxide)의 합성Synthesis of compound 1-10 ((4-(6,6-dimethyl-6H-indeno[1,2-j]fluoranthen-4-yl)phenyl)diphenylphosphine oxide)

Figure 112019113353101-pat00017
Figure 112019113353101-pat00017

둥근 바닥 플라스크에 중간체 D 혼합물 (5g, 12.5mmol)을 가한 후 diphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)phosphine oxide(6.1g, 15mmol), Pd(Pph3)4 (0.4g, 0.35mmol)을 가하고 톨루엔 50ml, 에탄올 25ml와 잘 섞어주었다. 증류수 25ml에 potassium carbonate (5g, 38mmol)을 녹인 후 플라스크에 가하였다. 24 시간 동안 환류시킨 후 실온으로 식혀준 뒤 과량의 메탄올로 석출시켜 여과 후 건조하였다. Methylene chloride로 컬럼 정제하여 화합물 1-10를 9.2g(74%) 얻었다. EI, MS m/z (%): 595 (100, M+)Intermediate D mixture (5g, 12.5mmol) was added to a round bottom flask, and then diphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)phosphine oxide (6.1g , 15mmol), Pd(Pph 3 ) 4 (0.4g, 0.35mmol) was added and mixed well with toluene 50ml and ethanol 25ml. After dissolving potassium carbonate (5g, 38mmol) in 25ml of distilled water, it was added to the flask. After refluxing for 24 hours, the mixture was cooled to room temperature, precipitated with excess methanol, filtered and dried. Column purification was performed with methylene chloride to obtain 9.2 g (74%) of compound 1-10. EI, MS m/z (%): 595 (100, M + )

하기 표 1은 합성된 물질들의 1H NMR과 MASS/FAB을 나타낸다. 상기 1H NMR 분석 결과에서 사용된 약자 중 s는 단일선, d는 이중선, t는 삼중선, g는 사중선, m은 다중선을 의미한다.Table 1 shows the 1 H NMR and MASS / FAB of the composite material. The 1 s of the abbreviation used in the H NMR analysis results of a singlet, d is doublet, t is triplet, g is quartet, m means multiplet.

Figure 112019113353101-pat00018
Figure 112019113353101-pat00018

[유기 EL소자의 제조][Manufacture of organic EL device]

1. 비교예 1의 제조예1. Preparation Example of Comparative Example 1

발광면적이 2mm × 2mm크기가 되도록 ITO 기판을 패터닝한 후, 이소프로필 알코올과 UV 오존으로 각각 세정을 실시하였다. 이후, ITO기판을 진공 증착 장치의 기판 홀더에 장착하고 진공도가 1×10-7 torr가 되도록 압력을 잡았다.After patterning the ITO substrate so that the emission area was 2 mm × 2 mm in size, washing was performed with isopropyl alcohol and UV ozone, respectively. Then, the ITO substrate was mounted on the substrate holder of the vacuum deposition apparatus, and the pressure was applied so that the degree of vacuum was 1×10 -7 torr.

먼저, HAT-CN 화합물을 진공 증착하여 5nm 두께로 형성하였다. 이 화합물은 제1 정공주입층으로 작용한다. 이 위에 제1 정공수송층으로 NPB 물질을 30nm 두께로 형성하였다. 이어서 제1 전자차단층으로 HT-1 물질을 10nm 두께로 형성하였다.First, a HAT-CN compound was vacuum-deposited to form a thickness of 5 nm. This compound acts as the first hole injection layer. On this, an NPB material was formed to a thickness of 30 nm as a first hole transport layer. Then, an HT-1 material was formed to a thickness of 10 nm as a first electron blocking layer.

이후 YGH-1물질을 호스트로, YGD-1 물질을 도판트로 약 10% 질량비가 되도록 30nm의 두께로 공증착하여 노란색 제1 발광층을 형성하였다. Thereafter, the YGH-1 material as a host and the YGD-1 material as a dopant were co-deposited to a thickness of 30 nm in a mass ratio of about 10% to form a yellow first light emitting layer.

이 발광층 위에 TmPyPB 화합물을 25nm 두께로 제1 전자수송층을 형성하였다. 이후 BPhen 물질에 Li물질을 2% 질량비가 되도록 10nm 두께로 공증착하여 N형 전하생성층을 형성하였다. 이후, P형 전하생성층으로 HAT-CN 화합물을 5nm 두께로 진공 증착하였다. 이물질은 제2 정공주입층으로도 활용된다. 이 위에 제2 정공수송층으로 NPB 물질을 60nm 두께로 형성하였다. 이어서 제2 전자차단층으로 HT-1 물질을 10nm 두께로 형성하였다.A TmPyPB compound was formed on the light emitting layer to have a thickness of 25 nm and a first electron transport layer. Thereafter, a Li material was co-deposited to a thickness of 10 nm in a 2% mass ratio on the BPhen material to form an N-type charge generation layer. Thereafter, a HAT-CN compound was vacuum-deposited to a thickness of 5 nm as a P-type charge generation layer. The foreign material is also used as the second hole injection layer. On this, an NPB material was formed to a thickness of 60 nm as a second hole transport layer. Then, an HT-1 material was formed to a thickness of 10 nm as a second electron blocking layer.

이후 CPB 물질을 호스트로, Ir 화합물을 도판트로 약 10% 질량비가 되도록 30nm의 두께로 공증착하여 노란색 제2 발광층을 형성하였다. 이 발광층위에 TmPyPB 화합물을 25nm 두께로 제2 전자수송층을 형성하였다. 이후 LiF 물질을 전자주입층으로 1nm두께로 진공 증착하였다. 마지막으로 Al을 100nm 두께로 증착시켜 음극을 형성하여 유기 EL 소자를 제작하였다.Thereafter, the CPB material as a host and the Ir compound as a dopant were co-deposited to a thickness of 30 nm in a mass ratio of about 10% to form a yellow second emission layer. A TmPyPB compound was formed on the light emitting layer to have a thickness of 25 nm and a second electron transport layer. Thereafter, the LiF material was vacuum-deposited to a thickness of 1 nm as an electron injection layer. Finally, Al was deposited to a thickness of 100 nm to form a cathode to fabricate an organic EL device.

Figure 112019113353101-pat00019
Figure 112019113353101-pat00019

2. 실시예 1의 제조예2. Preparation of Example 1

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층 물질만 화합물 1-1로 바꾸어 유기발광소자를 제작하였다.An organic light emitting diode was manufactured by changing only the N-type charge generation layer material to Compound 1-1, except that it was configured in the same manner as in the above-mentioned comparative example.

3. 실시예 2의 제조예3. Preparation of Example 2

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층 물질만 화합물 1-9로 바꾸어 유기발광소자를 제작하였다.An organic light-emitting device was manufactured by changing only the N-type charge generation layer material to Compound 1-9, except that it was configured in the same manner as in the above-mentioned Comparative Example.

4. 실시예 3의 제조예4. Preparation of Example 3

위에 전술한 비교예와 동일하게 구성하되, N형 전하생성층 물질만 화합물 1-10로 바꾸어 유기발광소자를 제작하였다.An organic light emitting diode was manufactured by changing only the N-type charge generation layer material to Compound 1-10, except that it was configured in the same manner as in the comparative example described above.

이하에는 상기 실시예 1 내지 3, 및 비교예 1의 유기발광소자의 구동전류, 구동전압, 전류효율 및 외부양자효율을 측정하여 이하의 표 2에 나타내었다.Hereinafter, the driving current, driving voltage, current efficiency and external quantum efficiency of the organic light emitting diodes of Examples 1 to 3 and Comparative Example 1 were measured and shown in Table 2 below.

Figure 112019113353101-pat00020
Figure 112019113353101-pat00020

실시예 1 내지 3의 구동전압과 전류효율 및 외부양자효율이 비교예 1과 비교하여 월등히 향상된 것을 알 수 있다.It can be seen that the driving voltage, current efficiency, and external quantum efficiency of Examples 1 to 3 were significantly improved compared to Comparative Example 1.

5. 비교예 2의 제조예5. Preparation Example of Comparative Example 2

발광면적이 2mm × 2mm 크기가 되도록 ITO 기판을 패터닝한 후, 이소프로필 알코올과 UV 오존으로 각각 세정을 실시하였다. 이후, ITO 기판을 진공 증착 장치의 기판 홀더에 장착하고 진공도가 1×10-7 torr가 되도록 압력을 잡았다. 이후 N2 분위기 하에 Plasma 처리를 3분간 하였다.After patterning the ITO substrate so that the emission area was 2mm × 2mm in size, washing was performed with isopropyl alcohol and UV ozone, respectively. Then, the ITO substrate was mounted on the substrate holder of the vacuum deposition apparatus, and the pressure was applied so that the degree of vacuum was 1×10 -7 torr. Thereafter, plasma treatment was performed for 3 minutes under N 2 atmosphere.

그리고 먼저, HAT-CN 화합물을 진공 증착하여 5nm 두께로 형성하였다. 이 화합물은 정공주입층으로 작용한다. 이 위에 제 1 정공수송층으로 NPB 물질을 50nm 두께로 형성하였다. 이어서 제2 정공수송층으로 HT-1 물질을 10nm 두께로 형성하였다.And first, a HAT-CN compound was vacuum-deposited to form a thickness of 5 nm. This compound acts as a hole injection layer. On this, an NPB material was formed to a thickness of 50 nm as a first hole transport layer. Then, an HT-1 material was formed to a thickness of 10 nm as a second hole transport layer.

이후 GH-1물질을 호스트로, GD-1물질을 도판트로 약 10% 질량비가 되도록 30nm의 두께로 공증착하여 녹색 발광층을 형성하였다. Thereafter, the GH-1 material as the host and the GD-1 material as the dopant were co-deposited to a thickness of 30 nm in a mass ratio of about 10% to form a green light emitting layer.

이 발광층위에 ET-1 화합물을 35nm 두께로 전자수송층을 형성하였다. 이후 LiF 물질을 증착하여 1nm 두께로 전자주입층을 형성하였다. 이후, Al을 100nm 두께로 증착시켜 음극을 형성하여 유기 EL 소자를 제작하였다.An electron transport layer was formed on the light emitting layer with an ET-1 compound having a thickness of 35 nm. Then, a LiF material was deposited to form an electron injection layer to a thickness of 1 nm. Thereafter, Al was deposited to a thickness of 100 nm to form a cathode, thereby manufacturing an organic EL device.

Figure 112019113353101-pat00021
Figure 112019113353101-pat00021

6. 비교예 3의 제조예6. Preparation Example of Comparative Example 3

위에 전술한 비교예 2와 동일하게 구성하되, 전자수송층 물질 ET-1만 ET-2로 바꾸어 유기발광소자를 제작하였다.An organic light emitting diode was manufactured by changing only the electron transport layer material ET-1 to ET-2, except that it was configured in the same manner as in Comparative Example 2 described above.

7. 실시예 4의 제조예7. Preparation of Example 4

위에 전술한 비교예 2와 동일하게 구성하되, 전자수송층 물질 ET-1만 화합물 1-1로 바꾸어 유기발광소자를 제작하였다.An organic light emitting device was manufactured in the same manner as in Comparative Example 2 described above, except that only the electron transport layer material ET-1 was replaced with Compound 1-1.

8. 실시예 5의 제조예8. Preparation of Example 5

위에 전술한 비교예 2와 동일하게 구성하되, 전자수송층 물질 ET-1만 화합물 1-9로 바꾸어 유기발광소자를 제작하였다.An organic light emitting device was fabricated in the same manner as in Comparative Example 2 described above, except that only the electron transport layer material ET-1 was replaced with Compound 1-9.

본 발명의 실시예 4 및 5, 비교예 2 및 3에 의해 제조된 유기전계 발광소자들에 10mA/cm2의 정전류를 가하여 포토리서치(photoresearch)사의 PR-670으로 발광 특성을 측정하였다. A constant current of 10 mA/cm 2 was applied to the organic light emitting diodes manufactured by Examples 4 and 5 and Comparative Examples 2 and 3 of the present invention, and luminescence characteristics were measured with a PR-670 manufactured by photoresearch.

이하에는 상기 실시예 4 및 5, 및 비교예 2 및 3의 유기발광소자의 구동전류, 구동전압, 전류효율 및 외부양자효율을 측정하여 이하의 표 3에 나타내었다.Hereinafter, the driving current, driving voltage, current efficiency, and external quantum efficiency of the organic light emitting devices of Examples 4 and 5 and Comparative Examples 2 and 3 were measured and shown in Table 3 below.

Figure 112019113353101-pat00022
Figure 112019113353101-pat00022

실시예 4 및 5의 구동전압과 전류효율 및 외부양자효율이 비교예 2 및 3과 비교하여 월등히 향상된 것을 알 수 있다.It can be seen that the driving voltage, current efficiency, and external quantum efficiency of Examples 4 and 5 are significantly improved compared to Comparative Examples 2 and 3.

본 발명은 반드시 이러한 실시예로 국한되는 것은 아니고, 본 발명의 기술사상을 벗어나지 않는 범위 내에서 다양하게 변형 실시될 수 있다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 그러므로, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The present invention is not necessarily limited to these embodiments, and various modifications may be made without departing from the technical spirit of the present invention. Therefore, the embodiments disclosed in the present invention are not intended to limit the technical spirit of the present invention, but to explain, and the scope of the technical spirit of the present invention is not limited by these embodiments. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The protection scope of the present invention should be construed by the following claims, and all technical ideas within the equivalent range should be construed as being included in the scope of the present invention.

Claims (7)

하기 화학식 1로 표시되는 플루오란텐 화합물:
[화학식 1]
Figure 112019113353101-pat00023

상기 Ar1은 수소, 치환 또는 치환되지 않는 탄소수 3 내지 60의 아릴기, 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 치환 혹은 치환되지 않은 탄소수 3 내지 60의 헤테로아릴기, 아릴아민기 및 2차 아민기로 이루어진 군으로부터 선택된다.
A fluoranthene compound represented by the following formula (1):
[Formula 1]
Figure 112019113353101-pat00023

Wherein Ar 1 is hydrogen, a substituted or unsubstituted C 3 to C 60 aryl group, a substituted or unsubstituted C 3 to C 60 heteroaryl group including one or more heteroatoms selected from nitrogen, oxygen and sulfur, arylamine group and secondary amine groups.
제1항에 있어서, 상기 Ar1은 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트릴기, 치환 또는 비치환된 나프타세닐기, 치환 또는 비치환된 피레닐기, 치환 또는 비치환된 바이페닐일기, 치환 또는 비치환된 p-터페닐기, 치환 또는 비치환된 m-터페닐기, 치환 또는 비치환된 크리세닐기, 치환 또는 비치환된 트리페닐레닐기, 치환 또는 비치환된 페릴레닐기, 치환 또는 비치환된 인데닐기, 치환 또는 비치환된 퓨라닐기, 치환 또는 비치환된 티오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 피라졸릴기, 치환 또는 비치환된 이미다졸일기, 치환 또는 비치환된 트리아졸일기, 치환 또는 비치환된 옥사졸일기, 치환 또는 비치환된 티아졸일기, 치환 또는 비치환된 옥사디아졸일기, 치환 또는 비치환된 티아디아졸일기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 벤조퓨라닐기, 치환 또는 비치환된 벤조티오페닐기, 치환 또는 비치환된 벤조이미다졸일기, 치환 또는 비치환된 인돌일기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 나프티리디닐기, 치환 또는 비치환된 벤즈옥사진일기, 치환 또는 비치환된 벤즈티아진일기, 치환 또는 비치환된 아크리디닐기, 치환 또는 비치환된 페나진일기, 치환 또는 비치환된 페노티아진일기, 치환 또는 비치환된 페녹사진일기, 치환 또는 비치환된 페난트롤리닐기, 치환 또는 비치환된 카바졸릴기, 및 치환 또는 비치환된 스피로비플루오레닐기로 이루어진 군으로부터 선택되는 것인 플루오란텐 화합물.According to claim 1, wherein Ar One is a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthryl group, a substituted or unsubstituted naphthacenyl group group, a substituted or unsubstituted pyrenyl group, a substituted or unsubstituted biphenylyl group, a substituted or unsubstituted p-terphenyl group, a substituted or unsubstituted m-terphenyl group, a substituted or unsubstituted chrysenyl group, a substituted or Unsubstituted triphenylenyl group, substituted or unsubstituted perylenyl group, substituted or unsubstituted indenyl group, substituted or unsubstituted furanyl group, substituted or unsubstituted thiophenyl group, substituted or unsubstituted pyrrolyl group, substituted Or an unsubstituted pyrazolyl group, a substituted or unsubstituted imidazolyl group, a substituted or unsubstituted triazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted oxa group Diazolyl group, substituted or unsubstituted thiadiazolyl group, substituted or unsubstituted pyridyl group, substituted or unsubstituted pyrimidinyl group, substituted or unsubstituted pyrazinyl group, substituted or unsubstituted triazinyl group, substituted Or an unsubstituted benzofuranyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted benzoimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted iso A quinolinyl group, a substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted naphthyridinyl group, a substituted or unsubstituted benzoxazinyl group, a substituted or unsubstituted benzthiazinyl group , substituted or unsubstituted acridinyl group, substituted or unsubstituted phenazinyl group, substituted or unsubstituted phenothiazinyl group, substituted or unsubstituted phenoxazinyl group, substituted or unsubstituted phenanthrolinyl group, substituted or unsubstituted A fluoranthene compound selected from the group consisting of a cyclic carbazolyl group, and a substituted or unsubstituted spirobifluorenyl group. 제1항에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화합물들로 이루어진 군으로부터 선택되는 것인 플루오란텐 화합물:
Figure 112019113353101-pat00024
The fluoranthene compound according to claim 1, wherein the compound represented by Formula 1 is selected from the group consisting of the following compounds:
Figure 112019113353101-pat00024
제1전극,
제2전극, 및
상기 제1전극과 제2전극 사이에 위치하는 1층 이상의 유기물층을 포함하며,
상기 유기물층 중 1층 이상은 제1항에 따른 플루오란텐 화합물을 포함하는 유기발광소자.
first electrode;
a second electrode, and
At least one organic material layer positioned between the first electrode and the second electrode,
At least one layer of the organic material layer is an organic light emitting device comprising the fluoranthene compound according to claim 1.
제4항에 있어서, 상기 유기물층은 발광층, 정공주입층, 정공수송층, 및 정공주입 및 정공수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하고, 상기 적어도 1개의 층은 제1항에 따른 플루오란텐 화합물을 포함하는 것을 특징으로 하는 유기발광소자.5. The method of claim 4, wherein the organic material layer comprises at least one layer selected from the group consisting of a light emitting layer, a hole injection layer, a hole transport layer, and a layer that simultaneously injects and transports holes, and the at least one layer comprises a first An organic light emitting device comprising the fluoranthene compound according to claim. 제4항에 있어서, 상기 유기물층은 발광층, 전자주입층, 전자수송층, 및 전자주입 및 전자수송을 동시에 하는 층으로 구성된 군으로부터 선택되는 적어도 1개의 층을 포함하고, 상기 적어도 1개의 층은 제1항에 따른 플루오란텐 화합물을 포함하는 것을 특징으로 하는 유기발광소자.5. The method of claim 4, wherein the organic material layer comprises at least one layer selected from the group consisting of a light emitting layer, an electron injection layer, an electron transport layer, and a layer that simultaneously injects and transports electrons, and the at least one layer comprises a first An organic light emitting device comprising the fluoranthene compound according to claim. 제4항에 있어서, 상기 유기물층은 적어도 1개의 전하생성층(Charge Generation Layer: CGL)을 포함하고, 상기 적어도 1개의 전하생성층은 제1항에 따른 플루오란텐 화합물을 포함하는 것을 특징으로 하는 유기발광소자.5. The method of claim 4, wherein the organic material layer comprises at least one charge generation layer (CGL), and the at least one charge generation layer comprises the fluoranthene compound according to claim 1 . organic light emitting device.
KR1020190140260A 2019-11-05 2019-11-05 Fluoranthene compound and organic light emitting element comprising the same KR102274449B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190140260A KR102274449B1 (en) 2019-11-05 2019-11-05 Fluoranthene compound and organic light emitting element comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190140260A KR102274449B1 (en) 2019-11-05 2019-11-05 Fluoranthene compound and organic light emitting element comprising the same

Publications (2)

Publication Number Publication Date
KR20210054300A KR20210054300A (en) 2021-05-13
KR102274449B1 true KR102274449B1 (en) 2021-07-08

Family

ID=75913376

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190140260A KR102274449B1 (en) 2019-11-05 2019-11-05 Fluoranthene compound and organic light emitting element comprising the same

Country Status (1)

Country Link
KR (1) KR102274449B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023090404A1 (en) * 2021-11-18 2023-05-25 東ソー株式会社 Condensed ring fluorene compound, material for organic electroluminescent element, and organic electroluminescent element

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101058103B1 (en) * 2008-04-15 2011-08-24 삼성모바일디스플레이주식회사 An organic light emitting device comprising a bipyridine compound and an organic film including the same
WO2014157574A1 (en) 2013-03-27 2014-10-02 出光興産株式会社 Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device

Also Published As

Publication number Publication date
KR20210054300A (en) 2021-05-13

Similar Documents

Publication Publication Date Title
US9306175B2 (en) Organic electroluminescent device
KR102221106B1 (en) Organic light-emitting Devices
KR102355739B1 (en) Organic electroluminescence element
KR20180022190A (en) Organic compounds and organic electro luminescence device comprising the same
KR20140037854A (en) Organic electroluminescent element
KR20120116272A (en) Novel compounds for organic electronic material and organic electroluminescence device using the same
KR102110833B1 (en) Heterocyclic compound and organic light emitting device comprising the same
KR20190058748A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20230023673A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102263845B1 (en) Organic compound and organic electroluminescent device comprising the same
CN106432096B (en) Compound derived from cis-stilbene/fluorene spirochete and photoelectric device thereof
KR20160078125A (en) Organic compound and organic electroluminescent device comprising the same
KR102148239B1 (en) benzo(b)fluoranthene compounds and organic light emitting diode comprising the same
KR102239793B1 (en) Phenanthroline compound and organic light emitting element comprising the same
CN111902412B (en) Compound having benzimidazole ring structure and organic electroluminescent element
KR101926769B1 (en) Phenanthroline compound substituted by pyridine and organic light emitting element comprising the same
KR102274449B1 (en) Fluoranthene compound and organic light emitting element comprising the same
KR20220146425A (en) Arylamine compounds and electronic devices using the same
KR20210007650A (en) Heterocyclic compound and organic light emitting device comprising the same
US11706981B2 (en) Organic light emitting device and compounds for use in same
US10505123B2 (en) Compound and organic electroluminescent device using same
EP3670517A1 (en) Polycyclic compound, composition and an organic electroluminescence device comprising the polycyclic compound or the composition
KR20180075127A (en) Phenanthroline compound and organic light emmiting diode having the same
KR101990049B1 (en) Phenanthroline compound and organic light emmiting diode having the same
US11505561B2 (en) Organic light emitting device and materials for use in same

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right